A jury in Philadelphia has returned a verdict in a lawsuit against Janssen Pharmaceuticals Inc., parent company Johnson and Johnson for failing to warn parents and doctors of an autistic boy about the dangers of the antipsychotic drug Risperdal. The jury awarded $2.5 million to a family because of the company’s failure to warn the>> Read More

On today’s WCUI installment of “Lawsuit or No Lawsuit”, GWC Injury Lawyers partner Lou Cairo discusses some common prescription drug and medical device-themed issues that may – or may not – be eligible for a damages lawsuit.  >> Read More

There have been repeated warnings that antibiotics usually don’t do the trick when it comes to most sore throats and bronchitis.  Yet, researchers have found that for over a decade doctors have kept prescribing antibiotics for these cases. It has been shown that the rate of these prescriptions have only dropped about 10%, possibly less,>> Read More

The U.S. Food and Drug Administration recently issued a new safety communication about the safety of Pradaxa (dabigatran etexilate mesylate). Pradaxa is a potentially dangerous pharmaceutical which is sparking a wave of product liability litigation. Praxada is a blood-thinning medication (anticoagulant) often prescribed to reduce the risk of stroke and blood clots in patients with>> Read More

Medical device maker Johnson & Johnson is deep into a product liability trial over its defective DePuy ASR hip implants. These all-metal hip implants have extraordinarily high failure rates and it appears that J&J was aware that its implants were defectively designed long before the company announced a recall. The current ASR case is one>> Read More

The first of what could be many lawsuits was filed by one of the thousands of passengers aboard the Carnival Triumph cruise ship, citing horrifying conditions that resulted in physical and emotional harm and alleging that Carnival was unable to provide a seaworthy ship and sanitary conditions. As has been reported by countless news outlets>> Read More

Two types of Medtronic drug infusion pumps have been recalled after it was found that the devices sometimes fail to deliver medicines. The device maker sent an urgent safety device notification to doctors in early November that the U.S. Food and Drug Administration has deemed to be a recall. Medtronic recently notified healthcare professionals that>> Read More

On May 18, 2011, the United States Food and Drug Administration (FDA) announced that new restrictions on the diabetes drug Avandia would be implemented starting on November 18. These new restrictions will essentially remove Avandia (along with similar drugs such as Avandamet and Avandaryl) from the shelves of the majority of U.S. Pharmacies. Patients who>> Read More

Food manufacturing giant Nestlé USA recently announced that it would recall some varieties of Nestlé NESQUIK Chocolate Powder due to concerns about salmonella. Nestlés recall comes after one of its calcium carbonate suppliers recalled its products because of salmonella reports. Salmonella contamination is one of the most common causes for food-based product liability lawsuits and>> Read More

Accutane is a popular prescription medication used to treat moderate to severe acne and has been prescribed to millions of people since its introduction to the market in 1982. In 2009, Roche Laboratories Inc., the United States pharmaceutical manufacturer responsible for the drug, issued a press release stating that it would be discontinuing the manufacture>> Read More

Doctors are urging diabetics taking a popular class of diabetes drugs to get regular vision checks. The New York Times recently reported that a class of drugs called thiazolidinediones has been linked to vision loss in patients. Studies indicate that the drugs can increase a patient’s risk of macular edema, which is a condition in>> Read More

According to a recent press release by the Food and Drug Administration (FDA), Darvon and Darvocet, the popular prescription pain medications manufactured by Xanodyne Pharmaceuticals, Inc., were withdrawn from the market on November 19, 2010 as part of an FDA recall. Darvon and Darvocet are brand versions of the opioid Propoxyphene, which was first approved>> Read More